Liraglutide and sitagliptin have no effect on intestinal microbiota composition: A 12-week randomized placebo-controlled trial in adults with type 2 diabetes

Preclinical data suggest that treatment with either glucagon-like peptide (GLP)-1 receptor agonists or dipeptidyl peptidase (DPP)-4 inhibitors could change the intestinal microbiome and thereby contribute to their beneficial (cardio)metabolic effects. Therefore, our study aimed to investigate the ef...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes & metabolism 2021-09, Vol.47 (5), p.101223-101223, Article 101223
Hauptverfasser:	Smits, Mark M., Fluitman, Kristina S., Herrema, Hilde, Davids, Mark, Kramer, Mark H.H., Groen, Albert K., Belzer, Clara, de Vos, Willem M., Cahen, Djuna L., Nieuwdorp, Max, van Raalte, Daniël H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Dipeptidyl peptidase 4 DPP-4 GLP-1 Glucagon-like peptide 1 Intestinal microbiota
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!